Tag archive for ‘Form F-1’
Gil Tanenbaum On Monday, November 3rd, 2014

Pharmaceutical NeuroDerm Prepares for NASDAQ IPO

NeuroDerm Ltd., an Israeli clinical stage pharmaceutical company which develops drugs for central nervous system (CNS) diseases, announced the launch of its initial public offering of 4.5 million ordinary More...

Wordpress site Developed by Fixing WordPress Problems